Immune Pharmaceuticals Inc. (IMNP) Declined -6.57% or -0.02 To Price $0.35 On Monday

Immune Pharmaceuticals Inc. (IMNP) declined -6.57% or -0.02 to $0.35. It is around 395961 shares traded, which is 103.46% compare to the average total volume 382701. The market cap of IMNP is $11.03 million. The year to date change is -36.22%. The 52 week price range is from $0.31 to $5.02. Price of IMNP have changed 8.73% during last week. It have changed 2.47% over last month, -39.84% over last 3 months, -77.31% over last 6 months and -83.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for IMNP is 0.40. It is 14.29% above current price. The 200-day Moving Averages for IMNP is 1.07. It is 205.71% above current price. The 52-week High is 5.02. It is 1334.29% from the current price. The 52-week Low is 0.31. It is -11.43% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of IMNP is 2.01 on 2018-03-29. Short % to float is 4.69%. There are some statistics of IMNP. It is has market cap $11.03 million. The share outstanding is 31.90 million. The average volume is 382701. The percent of top 15 Institution holding is 2.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of IMNP is -304.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of IMNP is -103.76%.


Share this post